During the past decade, Clinique de l'Espérance conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique de l'Espérance" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "European Paediatric Soft Tissue Sarcoma Study Group" with 1 trials sponsored, "Société des Produits Nestlé (SPN)" with 1 trials sponsored, "St. Anna Kinderkrebsforschung" with 1 trials sponsored and "University of Leicester" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique de l'Espérance" #1 collaborator was "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator, "Cooperative Weichteilsarkom Studie" with 1 trials as a collaborator, "Dutch Childhood Oncology Group" with 1 trials as a collaborator and "Italian Association for Pediatric Hematology Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinique de l'Espérance" are "Leukemia" (3 trials), "Allergy" (1 trials), "Childhood Malignant Fibrous Histiocytoma of Bone" (1 trials), "Kidney Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Clinique de l'Espérance" in a lesser frequency.

Most popular intervention types in "Clinique de l'Espérance" are "Drug" (6 trials), "Procedure" (4 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cytarabine" (3 trials), "allogeneic bone marrow transplantation" (2 trials), "conventional surgery" (2 trials), "daunorubicin hydrochloride" (2 trials) and "dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique de l'Espérance" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Clinique de l'Espérance". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinique de l'Espérance, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique de l'Espérance, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".